Research Article

High-Dose Toremifene as a Promising Candidate Therapy for Hormone Receptor-Positive Metastatic Breast Cancer with Secondary Resistance to Aromatase Inhibitors

Table 4

Drug cost per month in each common endocrine therapy in Japan on March 2019.

Endocrine therapyRegimenCommon side effectsDrug cost per 28 days (generic drug)

TAMTamoxifen 20 mg/dayHot flash, thrombosis7,294 JPY (1,590 JPY)
ANAAnastrozole 1 mg/dayHot flash, arthritis, osteoporosis11,301 JPY (4,312 JPY)
FULFulvestrant 500 mg/4 weeksPain at injection site101,584 JPY
EXE+mTORExemestane 25 mg/day
Everolimus 10 mg/day
Interstitial pneumonitis, stomatitis593,743 JPY (589,123 JPY)
LET+PALLetrozole 2.5 mg/day
Palbociclib 125 mg/day, 21 days
Bone marrow suppression, stomatitis487,931 JPY (477,694 JPY)
FUL+PALFulvestrant 500 mg/4 weeks
Palbociclib 125 mg/day, 21 days
Bone marrow suppression, stomatitis575,350 JPY
HD-TORToremifene 120 mg/dayHot flash, thrombosis25,368 JPY (13,079 JPY)

HD-TOR: high-dose toremifene.